Left Lateral Thoracotomy for Centrifugal Continuous-Flow Left Ventricular Assist Device Placement: An Analysis from the Mechanical Circulatory Support Research Network
- 1 November 2018
- journal article
- research article
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 64 (6) , 715-720
Abstract
Continuous-flow left ventricular assist devices (CF-LVADs) have revolutionized the management of patients with advanced heart failure. Alternative implant strategies are increasingly used for device placement. We reviewed our experience from the Mechanical Circulatory Support Research Network registry with the HeartWare centrifugal CF-LVAD (HVAD). From May 2004 to August 2015, 1,150 patients underwent primary CF-LVAD implantation at our institutions. Within this group, a total of 283 patients (25%) were implanted with the HVAD. A minimally invasive left lateral thoracotomy (MILT) implant strategy was used in 53 patients (20%), of which 22 (42%) were implanted off-pump. Median age at implant was 59 years and 183 patients (65%) were implanted as bridge-to-transplantation. Follow-up was 100% complete for a total of 302 patient-years of support. In-hospital mortality was 4.9% (14 patients), and was comparable between the conventional sternotomy (CS) and MILT cohorts (p = 0.15). Patients in the MILT cohort had a shorter median length of stay (p < 0.01) and had a lower incidence of postimplant pump thrombus (p = 0.02). Cumulative survival at the end of follow-up reached 84%, and was comparable between the two groups (p = 0.298). Multivariate analysis identified preoperative bilirubin level as the only independent predictor of survival. Surgical technique had no impact on survival. In this large, multicenter experience, data demonstrate excellent survival and adverse event profiles for patients supported with the HVAD technology, regardless of surgical implant technique. With constant advancements in device technology along with our increasing clinical experience with the newer techniques, minimally invasive LVAD implantation continues to evolve as a valuable alternative to CS in selected patients.Keywords
This publication has 33 references indexed in Scilit:
- Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patientsThe Journal of Heart and Lung Transplantation, 2013
- Anatomy and Physiology of the Right VentricleCardiology Clinics, 2012
- Echocardiographic Variables After Left Ventricular Assist Device Implantation Associated With Adverse OutcomeCirculation: Cardiovascular Imaging, 2011
- Off-Pump Implantation of the HeartWare HVAD Left Ventricular Assist Device Through Minimally Invasive IncisionsThe Annals of Thoracic Surgery, 2011
- Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomesThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Risk Factors Predictive of Right Ventricular Failure After Left Ventricular Assist Device ImplantationThe American Journal of Cardiology, 2010
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceNew England Journal of Medicine, 2009
- Left ventricular assist devicesHeart, 2009
- Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac SurgeryCirculation, 2007
- One Thousand Minimally Invasive Valve OperationsAnnals of Surgery, 2004